Colgate-Palmolive Company (CL) closed at $98.69 on November 5, 2026, down 0.1% from the previous close, on volume of 5,731,849 shares (30-day average 4,748,285).
Data as of November 5, 2026.
Colgate-Palmolive (CL) Gets a Hold from Bernstein
TipRanks (Tue, 3-Nov 7:57 AM ET)
Barclays Remains a Hold on Colgate-Palmolive (CL)
TipRanks (Tue, 3-Nov 4:28 AM ET)
New CEO at Clorox brings strong turnaround experience—Evercore ISI
Seeking Alpha News (Mon, 2-Nov 11:53 AM ET)
Colgate-Palmolive (CL) Receives a Buy from RBC Capital
TipRanks (Mon, 2-Nov 10:28 AM ET)
Wells Fargo Reaffirms Their Hold Rating on Colgate-Palmolive (CL)
TipRanks (Sun, 1-Nov 8:35 PM ET)
Colgate-Palmolive posts 60.2% gross margin in Q3 as it raises full-year profit outlook
Market Chameleon (Fri, 30-Oct 3:38 AM ET)
Colgate-Palmolive Announces 3rd Quarter 2026 Results
Business Wire (Fri, 30-Oct 6:55 AM ET)
Business Wire (Fri, 16-Oct 8:35 AM ET)
Tom's of Maine Introduces Hydroxyapatite Toothpaste to Meet Rising Consumer Demand
PRNewswire (Wed, 23-Sep 9:05 AM ET)
Colgate-Palmolive Declares Regular Quarterly Dividend
Business Wire (Thu, 17-Sep 4:35 PM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of November 6, 2026, CL stock price declined to $97.01 with 2,396,894 million shares trading.
CL has a beta of 0.22, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.02 to the broad based SPY ETF.
CL has a market cap of $77.12 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.97 earnings per share. This beat revenue expectation by $36 million and exceeded earnings estimates by $.05.
In the last 3 years, CL traded as high as $109.30 and as low as $74.55.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VO.
CL has outperformed the market in the last year with a price return of +28.9% while the SPY ETF gained +10.1%. CL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +4.6% and -0.4%, respectively, while the SPY returned -3.8% and -3.3%, respectively.
CL support price is $97.01 and resistance is $100.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.
